A Study of Adavosertib as Treatment for Uterine Serous Carcinoma

Clinical trial NCT04590248 · COMPLETED

Trial details

NCT number: NCT04590248
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Uterine Serous Carcinoma

Start date: 2020-11-30
Primary completion: 2022-05-23
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.